Evidence map›Paper›PMID 40354268›Full record

ArticleExperimental and clinical psychopharmacology2025

Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders.

Anthony N Nist, Daniel A R Cabral, Shuangshuang Xu, Allison N Tegge, Warren K Bickel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anthony N NistAddiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.
Daniel A R CabralAddiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.
Shuangshuang XuAddiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.
Allison N TeggeAddiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.
Warren K BickelAddiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.

Funding

Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral MarkersR01AA029135 · NIAAA · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Jungmeen Kim-Spoon, Allison N Tegge · 2022 to 2026
$3.5M
National Institutes of Health; National Institute on Alcohol Abuse and AlcoholismNIAAA NIH HHS R01 AA029135Virginia Tech Carilion; Fralin Biomedical Research Institute
6 · The paper itself

Abstract

The extant literature hints at the existence of substance-specific differences in rates of cross-commodity discounting (CCT). However, direct examinations are currently lacking. The present experiment aimed to replicate previous studies examining CCT of substances and to extend their findings by examining potential substance-specific relationships with discounting. Participants (

Indexed as

Delay DiscountingSubstance-Related DisordersAdolescentAdultFemaleHumansImpulsive BehaviorMaleRewardYoung Adult

Identifiers

PMID40354268
PMCPMC13071926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.